All Stories

  1. Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis

    Article • F1000Research, January 2020, Faculty of 1000, Ltd.

    MD PhD Arturo Panduro, Dr Xingshun Qi, Fatima Higuera-de la Tijera, Alfonso Vera, Nashla Hamdan, Ana Karen Salas, Emma Puron

  2. Contrast-Enhanced CT May Be a Diagnostic Alternative for Gastroesophageal Varices in Cirrhosis with and without Previous Endoscopic Variceal Therapy

    Article • Gastroenterology Research and Practice, October 2019, Hindawi Publishing Corporation

    Dr Xingshun Qi

  3. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease

    Article • Expert Review of Gastroenterology & Hepatology, April 2019, Taylor & Francis

    Dr Xingshun Qi

  4. Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence

    Article • Current Medical Research and Opinion, January 2019, Taylor & Francis

    Dr Xingshun Qi, Prof. Dr. Martin Rössle

  5. Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization

    Article • Therapeutic Advances in Gastroenterology, January 2019, SAGE Publications

    Dr Xingshun Qi

  6. Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence

    Article • Therapeutic Advances in Chronic Disease, January 2019, SAGE Publications

    Dr Xingshun Qi

  7. Successful pharmacotherapy for multiple acute decompensation events in a cirrhotic patient with acute-on-chronic liver failure: A case report

    Article • Journal of Translational Internal Medicine, December 2018, De Gruyter

    Dr Xingshun Qi

  8. Effect of Admission Time on the Outcomes of Liver Cirrhosis with Acute Upper Gastrointestinal Bleeding: Regular Hours versus Off-Hours Admission

    Article • Canadian Journal of Gastroenterology and Hepatology, November 2018, Hindawi Publishing Corporation

    Dr Xingshun Qi

  9. Portal Hypertension

    Article • Canadian Journal of Gastroenterology and Hepatology, November 2018, Hindawi Publishing Corporation

    Professor Mingyu Sun, Professor Fernando Gomes Romeiro, Dr Xingshun Qi, Andrea Mancuso

  10. Association of non-alcoholic fatty liver disease with thyroid function: a systematic review and meta-analysis

    Article • Digestive and Liver Disease, August 2018, Elsevier

    Dr Xingshun Qi

  11. ABO blood type and risk of hepatocellular carcinoma: a meta-analysis

    Article • Expert Review of Gastroenterology & Hepatology, July 2018, Taylor & Francis

    Dr Xingshun Qi

  12. Hypoxia-inducible factor may induce the development of liver fibrosis in Budd–Chiari syndrome by regulating CD248/endosialin expression: A hypothesis

    Article • Journal of Translational Internal Medicine, June 2018, De Gruyter

    Dr Xingshun Qi

  13. Prevalence of CALR mutations in splanchnic vein thrombosis: A systematic review and meta-analysis

    Article • Thrombosis Research, May 2018, Elsevier

    Dr Xingshun Qi

  14. Association of proton pump inhibitors with the risk of hepatic encephalopathy during hospitalization for liver cirrhosis

    Article • United European Gastroenterology Journal, April 2018, SAGE Publications

    Dr Xingshun Qi

  15. Acid suppression in patients treated with endoscopic therapy for the management of gastroesophageal varices: a systematic review and meta-analysis

    Article • Expert Review of Gastroenterology & Hepatology, April 2018, Taylor & Francis

    Dr Xingshun Qi

  16. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis

    Article • Digestive and Liver Disease, April 2018, Elsevier

    Dr Xingshun Qi

  17. Portal Hypertension in a Patient With Recurrent Pancreatic Cancer After Radiotherapy and Systemic Chemotherapy

    Article • Journal of Clinical and Experimental Hepatology, March 2018, Elsevier

    Dr Xingshun Qi

  18. Anticoagulation for Portal Vein Thrombosis in Cirrhosis: Selection of Appropriate Patients

    Article • Gastroenterology, February 2018, Elsevier

    Dr Xingshun Qi

  19. Clinical characteristics and outcomes of traditional Chinese medicine-induced liver injury: a systematic review

    Article • Expert Review of Gastroenterology & Hepatology, January 2018, Taylor & Francis

    Dr Xingshun Qi

  20. Xuebijing Injection Combined with Antibiotics for the Treatment of Spontaneous Bacterial Peritonitis in Liver Cirrhosis: A Meta-Analysis

    Article • Evidence-based Complementary and Alternative Medicine, January 2018, Hindawi Publishing Corporation

    Rolf Teschke, Professor Mingyu Sun, Professor Fernando Gomes Romeiro, Dr Xingshun Qi, Andrea Mancuso

  21. Should vasoconstrictors be considered in a cirrhotic patient with acute non-variceal upper gastrointestinal bleeding?

    Article • Journal of Translational Internal Medicine, December 2017, De Gruyter

    Dr Xingshun Qi

  22. Supersonic shear imaging for the diagnosis of liver fibrosis and portal hypertension in liver diseases: a meta-analysis

    Article • Expert Review of Gastroenterology & Hepatology, December 2017, Taylor & Francis

    Dr Xingshun Qi

  23. Rivaroxaban recanalized occlusive superior mesenteric vein thrombosis, but increased the risk of bleeding in a cirrhotic patient

    Article • Liver International, July 2017, Wiley

    Dr Xingshun Qi

  24. Liver-to-abdominal area ratio for predicting the in-hospital mortality in advanced liver cirrhosis

    Article • Postgraduate Medicine, May 2017, Taylor & Francis

    Professor Fernando Gomes Romeiro, Dr Xingshun Qi

  25. Pro-brain natriuretic peptide and Troponin T-hypersensitivity levels correlate with the severity of liver dysfunction in liver cirrhosis

    Article • The American Journal of the Medical Sciences, April 2017, Elsevier

    Dr Xingshun Qi

  26. Diagnostic accuracy of contrast-enhanced computed tomography for esophageal varices in liver cirrhosis: a retrospective observational study

    Article • Journal of Evidence-Based Medicine, February 2017, Wiley

    Dr Xingshun Qi

  27. Prognostic Assessment and Management of Liver Cirrhosis

    Article • BioMed Research International, January 2017, Hindawi Publishing Corporation

    Dr Xingshun Qi, Professor Fernando Gomes Romeiro, Andrea Mancuso

  28. Covered versus bare stents for transjugular intrahepatic portosystemic shunt: an updated meta-analysis of randomized controlled trials

    Article • Therapeutic Advances in Gastroenterology, October 2016, SAGE Publications

    Dr Xingshun Qi

  29. Characteristics of retractions related to faked peer reviews: an overview

    Article • Postgraduate Medical Journal, September 2016, BMJ

    Dr Xingshun Qi

  30. Effectiveness and Safety of Pleurodesis for Hepatic Hydrothorax: A Systematic Review and Meta-Analysis

    Article • Digestive Diseases and Sciences, July 2016, Springer Science + Business Media

    Dr Xingshun Qi

  31. Esophageal Stent for Refractory Variceal Bleeding: A Systemic Review and Meta-Analysis

    Article • BioMed Research International, January 2016, Hindawi Publishing Corporation

    Dr Xingshun Qi

  32. Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: A systematic review of the literature

    Article • Clinics and Research in Hepatology and Gastroenterology, December 2015, Elsevier

    Dr Xingshun Qi

  33. Benefit Stratification of Prophylactic Anticoagulation in Liver Cirrhosis: More Questions Than Answers

    Article • Clinical Gastroenterology and Hepatology, October 2015, Elsevier

    Dr Xingshun Qi

  34. Integrity of Data in a Randomized Controlled Trial

    Article • Radiology, September 2015, Radiological Society of North America (RSNA)

    Dr Xingshun Qi

  35. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study

    Article • Liver International, August 2015, Wiley

    Dr Xingshun Qi

  36. Diagnostic accuracy of data on aspartate aminotransferase to platelets index might be false in the paper by Tafarel et al.

    Article • European Journal of Gastroenterology & Hepatology, August 2015, Wolters Kluwer Health

    Dr Xingshun Qi

  37. Knowledge about non-invasive diagnostic tests for varices in liver cirrhosis: A questionnaire survey to the Gastroenterology Branch of the Liaoning Medical Association, China

    Article • Gastroenterology Report, July 2015, Oxford University Press (OUP)

    Dr Xingshun Qi

  38. Difference in Budd-Chiari syndrome between the west and china

    Article • Hepatology, June 2015, Wiley

    Dr Xingshun Qi

  39. Recurrent Budd-Chiari Syndrome Presenting with Lower Limb Ulcers

    Article • Journal of Clinical and Experimental Hepatology, June 2015, Elsevier

    Dr Xingshun Qi

  40. Online-to-print Lags and Baseline Number of Citations in 5 Science Citation Index Journals Related to Liver Diseases (2013–2014)

    Article • Journal of Clinical and Experimental Hepatology, June 2015, Elsevier

    Dr Xingshun Qi

  41. Tusanqi-Related Sinusoidal Obstruction Syndrome in China

    Article • Medicine, June 2015, Wolters Kluwer Health

    Dr Xingshun Qi

  42. Imbalance of Pro- vs. Anti-Coagulation Factors in Chinese Patients with Budd-Chiari Syndrome and Non-Cirrhotic Portal Vein Thrombosis

    Article • PLoS ONE, March 2015, PLOS

    Dr Xingshun Qi

  43. Thrombopoietin receptor agonists significantly increase the risk of portal vein thrombosis in liver diseases: Meta-analysis of RCTs

    Article • Thrombosis and Haemostasis, March 2015, Schattauer GmbH

    Dr Xingshun Qi

  44. Survival and prognostic indicators of Budd–Chiari syndrome: a systematic review of 79 studies

    Article • Expert Review of Gastroenterology & Hepatology, March 2015, Taylor & Francis

    Dr Xingshun Qi

  45. Portal vein thrombosis significantly improves the survival of cirrhotic patients awaiting liver transplantation: Should we accept the statistical results?

    Article • European Journal of Internal Medicine, March 2015, Elsevier

    Dr Xingshun Qi

  46. Association between portal vein thrombosis and survival of liver transplant recipients: a systematic review and meta-analysis of observational studies

    Article • Journal of Gastrointestinal and Liver Diseases, March 2015, Romanian Society of Gastroenterology and Heptatology

    Dr Xingshun Qi

  47. Clinical Outcomes of the Transplantation of Stem Cells from Various Human Tissue Sources in the Management of Liver Cirrhosis: A Systematic Review and Meta-Analysis

    Article • Current Stem Cell Research & Therapy, January 2015, Bentham Science Publishers

    Dr Xingshun Qi

  48. Role of D-dimer in the Development of Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis

    Article • Saudi Journal of Gastroenterology, January 2015, Medknow

    Dr Xingshun Qi

  49. Directions of odds ratios might be inappropriate in the paper by Tafarel et al.

    Article • European Journal of Gastroenterology & Hepatology, January 2015, Wolters Kluwer Health

    Dr Xingshun Qi

  50. Associations of Antiphospholipid Antibodies With Splanchnic Vein Thrombosis

    Article • Medicine, January 2015, Wolters Kluwer Health

    Dr Xingshun Qi

  51. Thrombotic risk factors in Chinese nonmalignant and noncirrhotic patients with portal vein thrombosis

    Article • European Journal of Gastroenterology & Hepatology, January 2015, Wolters Kluwer Health

    Dr Xingshun Qi

  52. Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature

    Article • Gastroenterology Research and Practice, January 2015, Hindawi Publishing Corporation

    Dr Xingshun Qi

  53. Diabetes is associated with an increased risk of in-hospital mortality in liver cirrhosis with acute upper gastrointestinal bleeding

    Article • European Journal of Gastroenterology & Hepatology, January 2015, Wolters Kluwer Health

    Dr Xingshun Qi

  54. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis of observational studies

    Article • European Journal of Internal Medicine, January 2015, Elsevier

    Dr Xingshun Qi

  55. MET inhibitors for treatment of advanced hepatocellular carcinoma: A review

    Article • World Journal of Gastroenterology, January 2015, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Xingshun Qi

  56. Nonselective beta-blockers in cirrhotic patients with no or small varices: A meta-analysis

    Article • World Journal of Gastroenterology, January 2015, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Xingshun Qi

  57. Splanchnic Vein Thrombosis: Etiology, Diagnosis, and Treatment

    Article • Gastroenterology Research and Practice, January 2015, Hindawi Publishing Corporation

    Dr Xingshun Qi

  58. Serum Liver Fibrosis Markers for Predicting the Presence of Gastroesophageal Varices in Liver Cirrhosis: A Retrospective Cross-Sectional Study

    Article • Gastroenterology Research and Practice, January 2015, Hindawi Publishing Corporation

    Dr Xingshun Qi

  59. Epidemiology of venous thromboembolism in patients with liver diseases: a systematic review and meta-analysis

    Article • Internal and Emergency Medicine, December 2014, Springer Science + Business Media

    Dr Xingshun Qi

  60. Large Paraesophageal Varices Causing Recurrent Hepatic Encephalopathy

    Article • The American Journal of the Medical Sciences, December 2014, Elsevier

    Dr Xingshun Qi

  61. Associations of Coagulation Factor V Leiden and Prothrombin G20210A Mutations With Budd–Chiari Syndrome and Portal Vein Thrombosis: A Systematic Review and Meta-analysis

    Article • Clinical Gastroenterology and Hepatology, November 2014, Elsevier

    Dr Xingshun Qi

  62. Percutaneous Transhepatic Biliary Metal Stent for Malignant Hilar Obstruction: Results and Predictive Factors for Efficacy in 159 Patients from a Single Center

    Article • CardioVascular and Interventional Radiology, October 2014, Springer Science + Business Media

    Dr Xingshun Qi

  63. A Trend Toward the Improvement of Survival After TIPS by the Use of Covered Stents: A Meta-Analysis of Two Randomized Controlled Trials

    Article • CardioVascular and Interventional Radiology, October 2014, Springer Science + Business Media

    Dr Xingshun Qi

  64. Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleeding

    Article • Journal of Clinical Gastroenterology, August 2014, Wolters Kluwer Health

    Dr Xingshun Qi

  65. Methylenetetrahydrofolate reductaseC677Tgene mutation and hyperhomocysteinemia in Budd-Chiari syndrome and portal vein thrombosis: A systematic review and meta-analysis of observational studies

    Article • Hepatology Research, May 2014, Wiley

    Dr Xingshun Qi

  66. Hepatobiliary and Pancreatic: Portal hypertension due to hepatic light chain deposition disease

    Article • Journal of Gastroenterology and Hepatology, May 2014, Wiley

    Dr Xingshun Qi

  67. Abdominal-Wall Varices in the Budd–Chiari Syndrome

    Article • New England Journal of Medicine, May 2014, New England Journal of Medicine (NEJM/MMS)

    Dr Xingshun Qi

  68. Prevalence of thrombotic risk factors in Chinese Budd–Chiari syndrome patients

    Article • European Journal of Gastroenterology & Hepatology, May 2014, Wolters Kluwer Health

    Dr Xingshun Qi

  69. Timing of transjugular intrahepatic portosystmic for Budd-Chiari syndrome: Still an open issue

    Article • Liver International, April 2014, Wiley

    Dr Xingshun Qi

  70. Management of portal vein thrombosis in liver cirrhosis

    Article • Nature Reviews Gastroenterology & Hepatology, April 2014, Springer Science + Business Media

    Dr Xingshun Qi

  71. Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: A meta-analysis

    Article • Journal of Gastroenterology and Hepatology, March 2014, Wiley

    Dr Xingshun Qi

  72. Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis

    Article • PLoS ONE, March 2014, PLOS

    Dr Xingshun Qi

  73. Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: A meta-analysis of randomized controlled trials

    Article • Journal of Gastroenterology and Hepatology, February 2014, Wiley

    Dr Xingshun Qi

  74. Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression

    Article • Hepatology, February 2014, Wolters Kluwer Health

    Dr Xingshun Qi

  75. Additional evidence form randomized controlled trial regarding anticoagulation for the improvement of liver function in cirrhotic patients

    Article • Clinics and Research in Hepatology and Gastroenterology, February 2014, Elsevier

    Dr Xingshun Qi

  76. Spontaneous resolution of portal vein thrombosis in cirrhosis: Where do we stand, and where will we go?

    Article • Saudi Journal of Gastroenterology, January 2014, Medknow

    Dr Xingshun Qi

  77. Complete remission of hepatocellular carcinoma after transarterial Chemoembolization combined with brivanib

    Article • Journal of Cancer Research and Therapeutics, January 2014, Medknow

    Dr Xingshun Qi

  78. Pharmacologic Prophylaxis of Portal Venous System Thrombosis after Splenectomy: A Meta-Analysis

    Article • Gastroenterology Research and Practice, January 2014, Hindawi Publishing Corporation

    Dr Xingshun Qi

  79. Transarterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Prognostic Factors in a Single-Center Study of 188 Patients

    Article • BioMed Research International, January 2014, Hindawi Publishing Corporation

    Dr Xingshun Qi

  80. Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Xingshun Qi

  81. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre

    Article • Liver International, November 2013, Wiley

    Dr Xingshun Qi

  82. Child-Na Score: A Predictive Model for Survival in Cirrhotic Patients with Symptomatic Portal Hypertension Treated with TIPS

    Article • PLoS ONE, November 2013, PLOS

    Dr Xingshun Qi

  83. Prevalence of hepatocellular carcinoma in Chinese Budd–Chiari syndrome patients

    Article • European Journal of Gastroenterology & Hepatology, October 2013, Wolters Kluwer Health

    Dr Xingshun Qi

  84. Radiofrequency Ablation Versus Hepatic Resection for Small Hepatocellular Carcinoma

    Article • Journal of Clinical Gastroenterology, October 2013, Wolters Kluwer Health

    Dr Xingshun Qi

  85. Find Duplicates among the PubMed, EMBASE, and Cochrane Library Databases in Systematic Review

    Article • PLoS ONE, August 2013, PLOS

    Dr Xingshun Qi

  86. Prevalence and risk factors of hepatocellular carcinoma in Budd–Chiari syndrome

    Article • European Journal of Gastroenterology & Hepatology, July 2013, Wolters Kluwer Health

    Dr Xingshun Qi

  87. Effect of Antithrombin, Protein C and Protein S on Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis

    Article • The American Journal of the Medical Sciences, July 2013, Elsevier

    Dr Xingshun Qi

  88. Prevalence of Covert Duplicate Publications in Budd-Chiari Syndrome Articles in China: A Systematic Analysis

    Article • The American Journal of Medicine, July 2013, Elsevier

    Dr Xingshun Qi

  89. Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial

    Article • BMJ Open, July 2013, BMJ

    Dr Xingshun Qi

  90. Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis

    Article • Hepatology Research, June 2013, Wiley

    Dr Xingshun Qi

  91. Large hepatic angiomyolipoma

    Article • Clinics and Research in Hepatology and Gastroenterology, June 2013, Elsevier

    Dr Xingshun Qi

  92. Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review

    Article • Asia-Pacific Journal of Clinical Oncology, May 2013, Wiley

    Dr Xingshun Qi

  93. Hepatobiliary and Pancreatic: Budd-Chiari syndrome with infra-hepatic obstruction of inferior vena cava

    Article • Journal of Gastroenterology and Hepatology, May 2013, Wiley

    Dr Xingshun Qi

  94. l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials

    Article • Journal of Gastroenterology and Hepatology, April 2013, Wiley

    Dr Xingshun Qi

  95. Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study

    Article • Journal of Digestive Diseases, March 2013, Wiley

    Dr Xingshun Qi

  96. Transjugular intrahepatic portosystemic shunt in the treatment of Budd–Chiari syndrome: a critical review of literatures

    Article • Scandinavian Journal of Gastroenterology, March 2013, Taylor & Francis

    Dr Xingshun Qi

  97. Nonmalignant Partial Portal Vein Thrombosis in Liver Cirrhosis: To Treat or Not to Treat?

    Article • Radiology, March 2013, Radiological Society of North America (RSNA)

    Dr Xingshun Qi

  98. Thrombotic risk factors in Chinese Budd-Chiari syndrome patients

    Article • Thrombosis and Haemostasis, February 2013, Schattauer GmbH

    Dr Xingshun Qi

  99. Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: A systematic review and meta-analysis of observational studies

    Article • Journal of Gastroenterology and Hepatology, February 2013, Wiley

    Dr Xingshun Qi

  100. Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis

    Article • Thrombosis Research, February 2013, Elsevier

    Dr Xingshun Qi

  101. Extrahepatic portal vein aneurysm

    Article • Clinics and Research in Hepatology and Gastroenterology, February 2013, Elsevier

    Dr Xingshun Qi

  102. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma

    Article • Hepatology, February 2013, Wiley

    Dr Xingshun Qi

  103. Percutaneous Recanalization for Budd-Chiari Syndrome: An 11-year Retrospective Study on Patency and Survival in 177 Chinese Patients from a Single Center

    Article • Radiology, February 2013, Radiological Society of North America (RSNA)

    Dr Xingshun Qi

  104. Familial Budd-Chiari Syndrome in China: A Systematic Review of the Literature

    Article • ISRN Hepatology, January 2013, Hindawi Publishing Corporation

    Dr Xingshun Qi

  105. Scientific Publications Regarding Liver Cirrhosis and Portal Hypertension in 6 Science Citation Index Hepatology Specialized Journals from 2009 To 2011

    Article • Journal of Liver Disease & Transplantation, January 2013, OMICS Publishing Group

    Dr Xingshun Qi

  106. Studies on immunoregulatory and anti-tumor activities of a polysaccharide from Salvia miltiorrhiza Bunge

    Article • Carbohydrate Polymers, January 2013, Elsevier

    Dr Xingshun Qi

  107. A Systematic Review and Meta-Analysis of Randomized Trials and Prospective Studies Comparing Covered and Bare Self-Expandable Metal Stents for the Treatment of Malignant Obstruction in the Digestive Tract

    Article • International Journal of Medical Sciences, January 2013, Ivyspring International Publisher

    Dr Xingshun Qi

  108. Restrictive vs liberal transfusion for upper gastrointestinal bleeding: A meta-analysis of randomized controlled trials

    Article • World Journal of Gastroenterology, January 2013, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Xingshun Qi

  109. Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd-Chiari syndrome or portal vein thrombosis

    Article • Journal of Gastroenterology and Hepatology, December 2012, Wiley

    Dr Xingshun Qi

  110. CT features of non-malignant portal vein thrombosis: A pictorial review

    Article • Clinics and Research in Hepatology and Gastroenterology, December 2012, Elsevier

    Dr Xingshun Qi

  111. Which journal published more randomized controlled trials in the field of cirrhosis and portal hypertension?

    Article • Liver International, November 2012, Wiley

    Dr Xingshun Qi

  112. Hepatobiliary and Pancreatic: Inferior mesenteric vein-left gonadal vein shunt aggravating hepatic encephalopathy

    Article • Journal of Gastroenterology and Hepatology, September 2012, Wiley

    Dr Xingshun Qi

  113. Hepatocellular carcinoma

    Article • The Lancet, August 2012, Elsevier

    Dr Xingshun Qi

  114. Drug-related adverse events may predict efficacy in sorafenib therapy for hepatocellular carcinoma

    Article • Hepatology, July 2012, Wiley

    Dr Xingshun Qi

  115. Lack of association between TNF-α gene promoter polymorphisms and pancreatitis: A meta-analysis

    Article • Gene, July 2012, Elsevier

    Dr Xingshun Qi

  116. Degree of Portal Vein Thrombosis Might Be Associated With Recanalization During Anticoagulation

    Article • Clinical Gastroenterology and Hepatology, July 2012, Elsevier

    Dr Xingshun Qi

  117. Splenic artery aneurysm

    Article • Clinics and Research in Hepatology and Gastroenterology, June 2012, Elsevier

    Dr Xingshun Qi

  118. Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: A prospective study

    Article • Journal of Gastroenterology and Hepatology, May 2012, Wiley

    Dr Xingshun Qi

  119. Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: A hypothesis

    Article • Medical Science Monitor, January 2012, International Scientific Literature

    Dr Xingshun Qi

  120. Hepatobiliary and Pancreatic: Hepatosplenic gamma-delta T-cell lymphoma

    Article • Journal of Gastroenterology and Hepatology, December 2011, Wiley

    Dr Xingshun Qi

  121. Transjugular Intrahepatic Portosystemic Shunt for Portal Cavernoma with Symptomatic Portal Hypertension in Non-cirrhotic Patients

    Article • Digestive Diseases and Sciences, December 2011, Springer Science + Business Media

    Dr Xingshun Qi

  122. Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature

    Article • Hepatology International, December 2011, Springer Science + Business Media

    Dr Xingshun Qi

  123. Hepatocellular carcinoma treated with sorafenib

    Article • Alimentary Pharmacology & Therapeutics, November 2011, Wiley

    Dr Xingshun Qi

  124. Coagulopathy of Chronic Liver Disease

    Article • New England Journal of Medicine, October 2011, New England Journal of Medicine (NEJM/MMS)

    Dr Xingshun Qi

  125. Reply to:Tips for portal vein thrombosis (pvt) in cirrhosis: Not only unblocking a pipe

    Article • Journal of Hepatology, October 2011, Elsevier

    Dr Xingshun Qi

  126. Cavernous vessels around a patent portal trunk in the liver hilum

    Article • Abdominal Imaging, July 2011, Springer Science + Business Media

    Dr Xingshun Qi

  127. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis in cirrhosis

    Article • Gut, July 2011, BMJ

    Dr Xingshun Qi

  128. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A systematic review

    Article • Journal of Gastroenterology and Hepatology, May 2011, Wiley

    Dr Xingshun Qi

  129. Stage of portal vein thrombosis

    Article • Journal of Hepatology, May 2011, Elsevier

    Dr Xingshun Qi

  130. Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis

    Article • Medical Hypotheses, April 2011, Elsevier

    Dr Xingshun Qi

  131. Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis

    Article • Alimentary Pharmacology & Therapeutics, March 2011, Wiley

    Dr Xingshun Qi

  132. JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis

    Article • Alimentary Pharmacology & Therapeutics, January 2011, Wiley

    Dr Xingshun Qi

  133. A Large Portal Vein: A Rare Finding of Recent Portal Vein Thrombosis

    Article • Case Reports in Gastroenterology, January 2011, Karger Publishers

    Dr Xingshun Qi

  134. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis

    Article • Journal of Hepatology, January 2011, Elsevier

    Dr Xingshun Qi

  135. Anticoagulation and variceal bleeding in non-cirrhotic patients with portal vein thrombosis

    Article • Internal and Emergency Medicine, November 2010, Springer Science + Business Media

    Dr Xingshun Qi

  136. Hepatobiliary and Pancreatic: Unusual venous collaterals with membranous obstruction of the inferior vena cava

    Article • Journal of Gastroenterology and Hepatology, November 2010, Wiley

    Dr Xingshun Qi

  137. Anticoagulation for Portal Vein Thrombosis in Cirrhosis

    Article • The American Journal of Medicine, September 2010, Elsevier

    Dr Xingshun Qi

  138. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: A meta-analysis

    Article • Journal of Gastroenterology and Hepatology, June 2010, Wiley

    Dr Xingshun Qi

  139. Degree of portal vein thrombosis

    Article • Hepatology, March 2010, Wiley

    Dr Xingshun Qi

  140. A Confusing Relationship Between Child–Turcotte–Pugh Class A and Compensated Cirrhosis

    Article • The American Journal of Gastroenterology, February 2010, Wolters Kluwer Health

    Dr Xingshun Qi

  141. Two hypotheses for decreasing hepatic encephalopathy risk after transjugular intrahepatic portosystemic shunt

    Article • Hepatology, December 2009, Wiley

    Dr Xingshun Qi

  142. The preferable treatment for cirrhotic portal vein thrombosis: Anticoagulation or transjugular intrahepatic portosystemic shunt?

    Article • Hepatology, August 2009, Wiley

    Dr Xingshun Qi